CME Group Inc.
DE ˙ XTRA ˙ US12572Q1058
217,80 € ↑3,15 (1,47%)
2026-06-03
AKTIENPREIS
SecurityDE:MX4A / CME Group Inc.
InstitutionGarner Asset Management Corp
Latest Disclosed Ownership11,340 shares
Latest Disclosed Value $ 3,349,178
Garner Asset Management Corp reports 0.57% decrease in ownership of MX4A / CME Group Inc.

On April 29, 2026 - Garner Asset Management Corp filed a 13F-HR form disclosing ownership of 11,340 shares of CME Group Inc. (DE:MX4A) valued at $2,896,803 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 3, 2026 disclosing 11,405 shares of CME Group Inc.. This represents a change in shares of -0.57% during the quarter. The current value of the position is $2,469,852 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-04-29 2026-03-31 13F CME GROUP COM 12572Q105 11,340 -65 -0.57 3,349 7.55 1.3135
2026-02-03 2025-12-31 13F CME GROUP COM 12572Q105 11,405 -272 -2.33 3,115 -1.27 1.1950
2025-11-10 2025-09-30 13F CME GROUP COM 12572Q105 11,677 900 8.35 3,155 6.20 1.2713
2025-08-13 2025-06-30 13F CME GROUP COM 12572Q105 10,777 -1,885 -14.89 2,970 -11.55 1.3732
2025-05-06 2025-03-31 13F CME GROUP COM 12572Q105 12,662 -718 -5.37 3,359 111,833.33 1.4742
2025-02-13 2024-12-31 13F CME GROUP COM 12572Q105 13,380 -14 -0.10 3 50.00 1.3950
2024-11-12 2024-09-30 13F CME GROUP COM 12572Q105 13,394 -9 -0.07 3 0.00 1.3124
2024-08-12 2024-06-30 13F CME GROUP COM 12572Q105 13,403 1,518 12.77 3 0.00 1.2458
2024-05-16 2024-03-31 13F CME GROUP COM 12572Q105 11,885 156 1.33 3 -99.92 1.2606
2024-02-14 2023-12-31 13F CME GROUP COM 12572Q105 11,729 930 8.61 2,414 120,550.00 1.1728
2023-11-14 2023-09-30 13F CME GROUP COM 12572Q105 10,799 3 0.03 2 0.00 1.2375
2023-08-15 2023-06-30 13F CME GROUP COM 12572Q105 10,796 -2,557 -19.15 2 0.00 1.1152
2023-05-15 2023-03-31 13F CME GROUP COM 12572Q105 13,353 -117 -0.87 3 0.00 1.1723
2023-02-14 2022-12-31 13F CME GROUP COM 12572Q105 13,470 451 3.46 2 -99.91 1.0866
2022-11-14 2022-09-30 13F CME GROUP COM 12572Q105 13,019 -1,092 -7.74 2,306 -20.18 1.1944
2022-07-29 2022-06-30 13F CME GROUP COM 12572Q105 14,111 1,418 11.17 2,889 -4.31 1.2306
2022-04-29 2022-03-31 13F CME GROUP COM 12572Q105 12,693 57 0.45 3,019 4.57 1.1836
2022-01-31 2021-12-31 13F CME GROUP COM 12572Q105 12,636 496 4.09 2,887 22.96 1.1747
2021-10-29 2021-09-30 13F CME GROUP COM 12572Q105 12,140 2,986 32.62 2,348 20.60 1.0612
2021-08-03 2021-06-30 13F CME GROUP COM 12572Q105 9,154 42 0.46 1,947 4.62 0.9071
2021-04-30 2021-03-31 13F CME GROUP COM 12572Q105 9,112 42 0.46 1,861 12.72 0.9426
2021-01-29 2020-12-31 13F CME GROUP COM 12572Q105 9,070 159 1.78 1,651 10.73 0.9040
2020-10-30 2020-09-30 13F CME GROUP COM 12572Q105 8,911 1,445 19.35 1,491 22.82 0.9743
2020-07-27 2020-06-30 13F CME GROUP COM 12572Q105 7,466 1,302 21.12 1,214 13.88 0.9051
2020-04-27 2020-03-31 13F CME GROUP COM 12572Q105 6,164 751 13.87 1,066 -1.93 0.9596
2020-01-17 2019-12-31 13F CME GROUP COM 12572Q105 5,413 249 4.82 1,087 -0.37 0.7530
2019-10-29 2019-09-30 13F CME GROUP COM 12572Q105 5,164 -36 -0.69 1,091 8.13 0.8125
2019-07-19 2019-06-30 13F CME GROUP COM 12572Q105 5,200 55 1.07 1,009 19.13 0.7799
2019-04-23 2019-03-31 13F CME GROUP COM 12572Q105 5,145 -50 -0.96 847 -13.31 0.6778
2019-01-29 2018-12-31 13F CME GROUP COM 12572Q105 5,195 -10 -0.19 977 10.27 0.8709
2018-10-29 2018-09-30 13F CME GROUP COM 12572Q105 5,205 0 0.00 886 3.87 0.6740
2018-07-19 2018-06-30 13F CME GROUP COM 12572Q105 5,205 -50 -0.95 853 0.35 0.6700
2018-04-27 2018-03-31 13F CME GROUP COM 12572Q105 5,255 -495 -8.61 850 1.19 0.7121
2018-01-30 2017-12-31 13F CME GROUP COM 12572Q105 5,750 -100 -1.71 840 5.79 0.7090
2017-10-27 2017-09-30 13F CME GROUP COM 12572Q105 5,850 0 0.00 794 8.32 0.7082
2017-08-14 2017-06-30 13F CME GROUP COM 12572Q105 5,850 5,850 733 0.6893
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.